Frontlight ResearchEarly access
Taking people in NetherlandsPhase 1
Tests a new under-the-tongue insulin in adults with type 1 diabetes
Tests a new sublingual insulin in adults with type 1 diabetes.
Key facts
- Who runs it
- Sublin B.V.
- Where
- Enschede, NetherlandsSee the site
- Trial code
- Registry title
- A Phase 1 study of a novel sublingual insulin formulation
- Status
- Recruiting
- Phase
- Phase 1
- People taking part
- 19 people, planned
- Started
- 7 Sept 2026
- Expected to end
- 1 Mar 2027
- Type of study
- Interventional
- Record updated
- 13 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for men aged 18 to 64 years with type 1 diabetes. It tests a new sublingual insulin formulation.
- Age
- 18 Years to 64 Years
- Sex
- Men only
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 64 years old?
Where in Netherlands
- Centre for Human Drug ResearchEnschede, NetherlandsTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).
- Plain-language title
- Tests a new under-the-tongue insulin in adults with type 1 diabetesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from 2025-521863-11-00, who can take part
- Record updated
- 13 November 2026